NEW YORK, July 31, 2015 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM) is pleased to congratulate EyeGate Pharmaceuticals Inc., a clinical-stage specialty pharmaceutical and drug delivery company, on its NASDAQ listing. Prior to joining NASDAQ, EyeGate traded on the OTCQB® Venture Stage Market operated by OTC Markets Group.
Since EyeGate began trading on OTCQB on February 13, 2015, the company's share price has increased approximately 67% to $18.40 and its 30-day average daily dollar volume has increased 66%.
"We are happy to congratulate EyeGate Pharmaceuticals on its graduation to NASDAQ from the OTCQB marketplace," said Jason Paltrowitz, Executive Vice President- Corporate Services of OTC Markets Group. "Trading on OTCQB enables companies to increase investor interest and build their shareholder base through transparent trading and the timely release of news and financial disclosure. We are proud to have contributed to EyeGate's accomplishments and wish the company and its management continued success as it takes the next step."
OTC Markets Group is the global leader in exchange graduates, advancing 83 companies to the New York Stock Exchange, NASDAQ and NYSE MKT in 2014. More than 400 additional companies have graduated from the marketplaces in the past four years.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial markets for 10,000 U.S. and global securities. Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. We organize these securities into markets to inform investors of opportunities and risks: the OTCQX® Best Market; the OTCQB® Venture Market; and the OTC Pink® Open Market. Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors. To learn more about how we create better informed and more efficient financial markets, visit www.otcmarkets.com.
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Saskia Sidenfaden, OTC Markets Group Inc., +1 (212) 896-4428, email@example.com
SOURCE OTC Markets Group Inc.